header logo image


Page 1,015«..1020..1,0141,0151,0161,017..1,0201,030..»

Why Puma Biotechnology, Trex, and National CineMedia Slumped Today – Motley Fool

May 6th, 2017 1:41 am

The stock market performed reasonably well on Friday, sending major benchmarks to gains of 0.25% to 0.5% on the day. Favorable news from the U.S. economy outweighed any concerns about geopolitical events occurring this weekend, including the much-awaited final phase of the French elections. The Dow regained the 21,000 level, and the S&P 500 finished just below the 2,400 mark. But some stocks missed out on the rally, and Puma Biotechnology (NASDAQ:PBYI), Trex (NYSE:TREX), and National CineMedia (NASDAQ:NCMI) were among the worst performers on the day. Below, we'll look more closely at these stocks to tell you why they did so poorly.

Shares of Puma Biotechnology fell 16% after the biotech company said in an SEC filing that an executive in charge of regulatory affairs and project management would resign from the company effective May 15. The filing said that Dr. Robert Charnas had told Puma last week about his departure, with the filing citing health reasons for the move. Yet investors seem to be nervous about the timing, coming immediately before a key advisory panel meeting for its neratinib treatment for breast cancer. Given that neratinib has seen patients in trials report negative side effects, some investors believe that Puma might have trouble getting a positive recommendation from the panel when it meets later this month. The stock's decline might prove to be an overreaction, but the company's decision to put the information in a filing rather than doing a full press release might have contributed to investors' skepticism about the move.

Image source: Trex.

Trex stock declined 9% in the wake of the company releasing its first-quarter financial results. The home deck and railing specialist said that sales climbed 10% from year-ago figures, with increasing margins helping to produce an 18% rise in net income. Trex has gotten a lot of accolades from its industry, including kudos for its environmentally friendly practices and its leadership role in promoting alternatives to traditional wood decking and railing materials. Yet guidance for sales of $160 million in the second quarter only matched investor expectations, and despite calls for improving market share and margin figures, Trex investors seemed to want more from the decking specialist as the high spring season for home improvement begins.

Finally, shares of National CineMedia lost more than a quarter of their value. The in-theater media company said that revenue was down 6% from the year-ago quarter, leading to a drop in operating income and a wider net loss compared to the first quarter of 2016. Despite gains in sales from its local and regional segment as well as its digital and beverage businesses, softness in national advertising revenue weighed on the company's overall results. CEO Andy England reiterated that he sees 2017 as "a transitional year for NCM as we evolve from being the largest cinema network into a truly progressive, integrated digital media company." That means investors have to expect tough results this year, and National CineMedia's guidance called for revenue to fall 1% to 6% and produce a 6% to 12% drop in adjusted operating income. As movie theaters struggle to get people to leave their homes for entertainment, National CineMedia will have to work harder to find new avenues for growth.

Dan Caplinger has no position in any stocks mentioned. The Motley Fool owns shares of and recommends Trex. The Motley Fool has a disclosure policy.

See the original post:
Why Puma Biotechnology, Trex, and National CineMedia Slumped Today - Motley Fool

Read More...

Why Puma Biotechnology Shares Are Crashing 18.2% Today – Motley Fool

May 6th, 2017 1:41 am

What happened

Puma Biotechnology(NASDAQ:PBYI) stock has plummeted 18.2% as of 12:53 p.m. EDT following news that Dr. Robert Charnas, its head of regulatory affairs and project management, is hitting the exits ahead of a scheduled Food and Drug Administration (FDA) advisory panel meeting on May 24.

Puma Biotechnology has only one product in its clinical-stage drug pipeline, and that drug, neratinib, has been the subject of a lot of scrutiny after trials showed that a large number of patients taking it suffered from high-grade diarrhea.

Image source: Getty Images.

Puma Biotech's CEO Alan Auerbach hired Charnaslast year to help get neratinib across the regulatory finish line. Previously,Charnas worked at Johnson & Johnson in its research and development department. He was responsible for ongoing development of Zytiga, a prostate cancer drug that J&J acquired in 2009 when it bought Auerbach's previous company, Couger Biotech. Charnas joined Cougar in 2008.

Yesterday, Puma Biotech said Charnas is leaving because of health reasons. However, there's some conflicting information circulating that there may have been some disagreements between him and his co-workers. If so, no one is saying for sure what those disagreements were about.

News of his departure so close to the FDA advisory committee meeting is disconcerting, regardless of Charnas' reasons for leaving.

After all, neratinib is far from a lock to win the committee's recommendation for approval. It's being considered as an extended maintenance therapy to help delay disease recurrence in breast cancer patients who have previously been treated for one year with Herceptin. In trials, neratinib hit its mark in terms of efficacy, but many of its patients reported severe diarrhea.

In hopes of overcoming a rejection because of this safety risk, Puma Biotech has been studying the use of the anti-diarrhea drug loperamide and steroids alongside neratinib. Ideally, a diarrhea incidence rate below 20% would be desirable, but interim trial results showed a 27% rate of grade 3 or higher diarrhea when using loperamide. Steroids may lower that rate further, but their use can cause other unwanted side effects.

It's anyone's guess what will happen at the advisory committee meeting, or what the FDA will ultimately decide to do with neratinib's application. Nevertheless, I think the risk of failure is too high to recommend buying shares ahead of a decision.

Todd Campbell has no position in any stocks mentioned.His clients may have positions in the companies mentioned. The Motley Fool owns shares of and recommends Johnson & Johnson. The Motley Fool has a disclosure policy.

The rest is here:
Why Puma Biotechnology Shares Are Crashing 18.2% Today - Motley Fool

Read More...

iShares NASDAQ Biotechnology Index (IBB) Position Maintained by Ausdal Financial Partners Inc. – The Cerbat Gem

May 6th, 2017 1:41 am

The Cerbat Gem
iShares NASDAQ Biotechnology Index (IBB) Position Maintained by Ausdal Financial Partners Inc.
The Cerbat Gem
iShares NASDAQ Biotechnology Index logo Ausdal Financial Partners Inc. continued to hold its stake in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) during the first quarter, according to its most recent Form 13F filing with the SEC. The ...
Appleton Partners Inc. MA Cuts Stake in iShares NASDAQ Biotechnology Index (IBB)Transcript Daily
Commerzbank Aktiengesellschaft FI Has $20.843 Million Stake in iShares NASDAQ Biotechnology Index (IBB)Markets Daily
iShares NASDAQ Biotechnology Index Sees Unusually Large Options Volume (IBB)Sports Perspectives
BBNS -Chaffey Breeze -Community Financial News
all 44 news articles »

See the original post:
iShares NASDAQ Biotechnology Index (IBB) Position Maintained by Ausdal Financial Partners Inc. - The Cerbat Gem

Read More...

Knee ‘Crackle’ Might Mean Arthritis is Coming – WebMD

May 6th, 2017 1:41 am

By Amy Norton

HealthDay Reporter

FRIDAY, May 5, 2017 (HealthDay News) -- Knees that "pop," "click" or "crackle" may sometimes be headed toward arthritis in the near future, a new study suggests.

It's common for the knees to get a little noisy on occasion, and hearing a "crack" during your yoga class is probably not something to worry about, experts say.

But in the new study, middle-aged and older adults who said their knees often crackled were more likely to develop arthritis symptoms in the next year.

Of those who complained their knees were "always" noisy, 11 percent developed knee arthritis symptoms within a year. That compared with 4.5 percent of people who said their knees "never" popped or cracked.

Everyone else fell into the middle. Of people who said their knees "sometimes" or "often" made noise, roughly 8 percent developed knee arthritis symptoms in the next year.

Doctors have a term for those joint noises: crepitus.

Patients commonly complain of it, said Dr. Grace Lo, the lead researcher on the study. She's an assistant professor at Baylor College of Medicine in Houston.

But until now, it hasn't been clear whether crepitus can predict symptomatic knee arthritis. That means people not only have evidence of cartilage breakdown on X-rays, but also suffer symptoms from it -- namely, frequent pain and stiffness.

"Our study suggests crepitus is not completely benign," Lo said. "It's a sign that something is going on in the knee joint."

Dr. Joseph Bosco, an orthopedic surgeon who wasn't involved in the study, agreed that frequent crepitus should be checked out.

"A lot of people's knees 'snap' and 'pop,'" said Bosco, a professor at NYU Langone Medical Center in New York City. "Do they need to run out for knee replacements? No."

But, he added, "if you experience crepitus regularly, get an evaluation."

The findings, published May 4 in the journal Arthritis Care & Research, come with some caveats.

The nearly 3,500 study participants were at increased risk of developing knee arthritis symptoms to begin with, Lo explained.

The participants ranged in age from 45 to 79. Some were at risk of knee arthritis simply because of old age, while others had risk factors such as obesity or a history of a significant knee injury.

So it's not clear, Lo said, whether the findings would translate to -- for example -- a 35-year-old whose knees crack when she runs.

Plus, even though the study participants were initially free of knee arthritis symptoms, some did have signs of arthritis damage on an X-ray.

And it was in that group where crepitus was a red flag: People who "often" or "always" had noisy knees were nearly three times more likely to develop knee arthritis symptoms as those who "never" had crepitus.

According to Lo, the findings could be useful in everyday medical practice. "If patients are complaining of frequent cracking or popping in the knees," she said, "get an X-ray."

If that turns up signs of arthritic damage, Lo said, then the risk of progressing to symptoms in the near future is probably significant.

Unfortunately, there is no magic pill that can stop arthritis in progress. But, Lo said, for patients who are heavy, weight loss can help.

Some, she added, might benefit from strengthening the muscles that support the knees.

WebMD News from HealthDay

SOURCES: Grace Lo, M.D., assistant professor, medicine, Baylor College of Medicine, Houston; Joseph Bosco, M.D., professor, orthopedic surgery, NYU Langone Medical Center, New York City; May 4, 2017, Arthritis Care & Research

Go here to read the rest:
Knee 'Crackle' Might Mean Arthritis is Coming - WebMD

Read More...

Rheumatoid Arthritis Deaths Have Decreased – Healthline

May 6th, 2017 1:41 am

Many study findings about rheumatoid arthritis (RA) sound negative, but patients with the disease are now getting some encouraging news.

A study published last month on the progress and advancements in RA treatment and management revealed that for the first time in years the mortality rate among people with RA has decreased.

Researchers also noted that people with the disease experience much less disability than in decades past.

Read more: Green tea may help ease rheumatoid arthritis treatments

Data from the World Health Organization (WHO) shows that RA was listed as the underlying cause of death in 8,428 cases in 2011.

That was a decrease from 9,281 deaths in 1987.

The age-standardized mortality rate of RA declined by 3 percent annually from 1987 to 2011.

But people with RA still have a higher mortality rate than the general population.

The Centers for Disease Control and Prevention (CDC) notes thatearly treatment within six months of diagnosis is ideal to help curb aggressive disease activity or early deaths from RA.

Read more: Stem cell therapy a possible treatment for rheumatoid arthritis

Researchers are now trying to ascertain which specific approaches have helped bring down the RA mortality rate.

In general, it seems that the long-term outlook for people with RA is improving but only with early treatment. This was evidenced in a study following a group of people with RA for 20 years.

Early treatment means getting the right diagnosis and catching the RA early in the progression of the disease.

There are some mixed opinions within the rheumatology community about what the first line of defense is in RA treatment, but the general consensus is that a more aggressive approach in the earlier stages is best.

People with lower disease activity tended to fare better long term.

But, overall, while people with RA reported a lower disease activity early on, disability rates did tend to rise in people with RA seven years after diagnosis.

The disability reported was moderate but still better than compared with previous decades.

A press release about these discoveries noted that patients who received treatment within the first six months had a lower risk of death than those who did not receive treatment, after controlling for disease severity.

This research emphasizes the importance of early treatment and the long-term benefits of early treatment, said Suzanne Verstappen, PhD, a senior research fellow at the University of Manchester, and a lead researcher on these study, said in a press statement. In the early 1990s, when this study started, only 30 percent of patients received early treatment, but this number has increased significantly in the last decade. It's expected that in the next 10 years, newly diagnosed patients will have a better future with respect to functional ability, less severe disease activity, and improved quality of life.

Read more: Why rheumatoid arthritis is plaguing 9/11 first responders

In the past, there was a higher RA mortality rate due to complications such as lung and heart issues associated with severe RA disease activity.

Other people succumbed to fatal infections from RA medications, or other unique complications associated with RA and its comorbidities.

The higher survival rate is welcome news for people with RA, but there are issues related to living longer with the disease.

Although increased survival with rheumatoid arthritis is great news, it might lead to a greater share of our aging population having the disease and in need of health services. This needs to be accounted for in healthcare planning, said study lead author Aliasghar Kiadaliri, PhD, of Lund University in Sweden, in a statement to the press.

People with RA, though, still look at this news as a positive thing.

With so much bad news regarding the healthcare bill and funding for NIH research being cut and just the difficulties of RA in general, it is nice to get good news for once. I would love to live a longer and healthier life even with having a serious illness like RA, said Jacqueline Dickson of North Carolina.

I am only 23 and was just recently diagnosed with rheumatoid arthritis, added Michelle Herbert of Nevada. I wondered if it would affect my life expectancy, and told my doctor that Id try whatever she suggested to make sure my disease didnt progress too badly. Its good to know that aggressive treatment early in the disease is seen as a positive, but I just hope my doctors caught it in time because I had so many years of pain.

Perhaps Brad Smith of New York, a young man with RA, is the one to sum it up best.

Ill takeanygood news when it comes to RA, he said.

Continue reading here:
Rheumatoid Arthritis Deaths Have Decreased - Healthline

Read More...

Arthritis symptoms – THIS condition could be triggered by bowel infection and last months – Express.co.uk

May 6th, 2017 1:41 am

Reactive arthritis can cause painful joint swelling and in most cases it clears up completely within months..

The condition - whihc is different to osteoarthritis and rheuamtoid arthritis - most commonly develops after infections of the bowel or genital tract.

Arthritis Research UK said: Unlike septic arthritis, reactive arthritis isnt caused by an active infection within your joints.

With reactive arthritis the inflammation in your joints is a reaction to an infection elsewhere in your body. Reactive arthritis is diagnosed if you suddenly develop arthritis, especially in your knees or ankles, just after suffering an infection.

GETTY

Sometimes the infection may have been so mild that you didn't notice it.

The charity said the first signs of the condition can be pain and swelling, usually in the joints in the legs - knees ankles or toes.

It said the swelling may happen suddenly or develop over a few days after the affected joint becomes stiff.

Other joints including the fingers, wrists, elbows and the joints at the base of your spine (sacroiliac joints) can also become inflamed.

Getty

1 of 12

GETTY

ith reactive arthritis the inflammation in your joints is a reaction to an infection elsewhere in your body

Reactive arthritis can also cause inflammation of the tendons around the joints, such as the Achilles tendon at the back of the ankle.

Joint pain and swelling are often the only symptoms of reactive arthritis. But other possible symptoms include:

inflamed, red eyes (conjunctivitis) scaly rashes over your hands or feet (known as keratoderma blenorrhagica) diarrhoea, which may start some time before the arthritis mouth ulcers inflammation of the genital tract which produces a discharge from your vagina or penis a sore rash over the end of the penis weight loss and fever.

GETTY

The charity said reactive arthritis can affect people of all ages, including children.

It generally affects a younger average age group than rheumatoid arthritis or osteoarthritis.

Although there isnt a family tendency to develop reactive arthritis, if you have a particular gene, HLA-B27, you may be more likely to develop the condition.

This gene is carried by about one in 14 - seven per cent - of the general population.

The charity said: Having the HLA-B27 gene could also make you more likely to have further episodes of reactive arthritis in the future.

To find out more visit Arthritis Research UK

Excerpt from:
Arthritis symptoms - THIS condition could be triggered by bowel infection and last months - Express.co.uk

Read More...

Study: 4 in 10 people will have hand arthritis in lifetime – Wichita Eagle

May 6th, 2017 1:41 am
Study: 4 in 10 people will have hand arthritis in lifetime
Wichita Eagle
Hand arthritis is more common than you might think. Nearly one in two women and one in four men will develop the condition in their lifetime, according to a new study. The risk of symptomatic hand osteoarthritis also varies by race and weight. Aching ...
Symptomatic Hand Osteoarthritis Will Affect 40 Percent of PeopleDoctors Lounge

all 2 news articles »

Read this article:
Study: 4 in 10 people will have hand arthritis in lifetime - Wichita Eagle

Read More...

Frank Haight: Second-grader bravely fighting painful arthritis – Columbia Daily Tribune

May 6th, 2017 1:41 am

She's only a second grader at Cordill-Mason Elementary School in Blue Springs, but 8-year-old Maggie Miller knows what it's like to attend class with every joint on her fingers, wrists and elbows hurting from juvenile idiopathic arthritis, a disease with no cure yet.

What's happening to Maggie is this: Her immune system sees healthy cells as bad, and her immune system attacks the healthy cells in her body, explains Maggie's mom, Tammy Miller. So her immune system is attacking all her joints.

That's the bad news. The good news is: We have been able to stop the spread of (the disease), she says, recalling the disease spread quickly after Maggie was diagnosed with juvenile arthritis in October 2015. We have been able to slow down the progression of the disease with a lot of medicine that she takes weekly, and every four weeks we go into the hospital and do an IV infusion treatment . ... and we do an injection of chemo every weekend to kind of suppress the immune system from attacking her body.

How is Maggie coping with her affliction?

Maggie is the strongest, bravest child I know. She deals with more than any 8-year-old should ever have to deal with. She has to deal with a lot of medicines, doctor appointments and physical therapy, occupational therapy and pool therapy, Tammy says, recalling Maggie had two appointments this week and missed a lot of schooling and doing fun things with her friends.

However, the fun Maggie missed doing with her friends, she more than made up when the Dream Factory of Kansas City sent the Miller family, including her father, Duane, and her 11-year-old brother, Joel, to Orlando, Florida. There they spent March 11 to 17 visiting Disney World, Universal Studios and Sea World.

Then, there was the 80-acre Give Kids the World Village where Dream Factory and Make-A-Wish Foundation families stayed while in Orlando. There were tons of fun things to do, Tammy says, recalling the Village each night staged an elaborate party or celebration like Halloween, with a visit from the Storm Troopers and other characters. Then there was Christmas in March, complete with Santa, snow, sleigh rides and much more.

Wearing Mickey Mouse ears to an interview earlier this week was soft-spoken Maggie who fielded a few questions. Her favorite park ride was scary Splash Mountain. Cinderella's evil stepsisters were her favorite meet-and-greet characters, because they were ugly and stayed in character and acted evil. And the ride she hated most: The Tower of Terror, which made her scream.

How did the trip of a lifetime affect Maggie, who says she would like to go to Los Angeles someday and see her two favorite TV personalities, Ellen Degeneres and Steve Harvey.

It was really nice to go on this trip and get away from hospitals, doctors, therapy and just be a family and just have fun and let (Maggie) be a kid and do kid things for a while, she says, noting: We went to seven parks in that short time.

On Saturday, May 6, Maggie and her team of walkers will be helping The Arthritis Foundation, which Tammy says has been an amazing support system for her family. For the second consecutive year, Maggie's team of fundraisers are participating in the annual Walk to Cure Arthritis, a community fundraising 5K walk. The event begins at 9 a.m. in the dinosaur section of Worlds of Fun before the park opens.

What's ahead for Maggie?

Says Tammy: We are going to continue our treatment. Our goal is hopefully to get (the disease) to go into remission so that we can go into a medication remission and there be no signs of the disease. Then hopefully, we can start weaning off some of those medicines and stay in remission.

What has already begun as a fun-filled year for Maggie will continue next month when Maggie spends June 5 to 8 at The Arthritis Foundation's Camp Joint Adventure at Lawson, Missouri. She will be attending camp (where memories are made) on a scholarship. One of her memories, no doubt, will be swimming, because that's her favorite pastime and doesn't put much pressure on her joints.

(Maggie) is looking forward to participating in the 5K walk and going to camp this summer in order to be with other kids who understand her disease, Tammy says. ...She has a real strong support group of friends, and has told her class what her disease is, how it affects her and why she is away from school sometimes because of appointments. She has to miss all day on infusion treatment day. Then she is worn out afterwards.

Will Maggie's condition worsen?

With the advancement in medication treatment, we hope we have been able to catch it in time, get on the right medicine in a timely fashion and that we have the disease under control, Tammy says, explaining, There is always that chance medicines will stop working, and we pray that won't happen. But if it does, we will regroup, find a new treatment and try it. ...It's all about trying to find the right combinations of medicine. We are very lucky we were able to slow down the disease before it got to any other joints.

-- Retired community news reporter Frank Haight Jr. writes this column for The Examiner. You can leave a message for him at 816-350-6363.

See original here:
Frank Haight: Second-grader bravely fighting painful arthritis - Columbia Daily Tribune

Read More...

National Arthritis Awareness Month: Family Caregivers Key to … – Benzinga

May 6th, 2017 1:41 am

This month, America observes Arthritis Awareness Month a month dedicated to sharing experiences and letting others see and hear about the disease and its impacts. To join in the discussion, Home Instead Senior Care the world's leading provider of in-home care services for seniors is offering tips to family caregivers of those living with the disease.

OMAHA, Neb. (PRWEB) May 05, 2017

Arthritis is the No. 1 cause of disability in the United States, affecting more than 50 million Americans, according to the Arthritis Foundation. Those with this chronic disease experience painful inflammation and stiffness, making it difficult to accomplish daily tasks, which can lead to anxiety or a diminished positive self-image.

This month, America observes Arthritis Awareness Month a month dedicated to sharing experiences and letting others see and hear about the disease and its impacts. To join in the discussion, Home Instead Senior Care the world's leading provider of in-home care services for seniors is offering tips to family caregivers of those living with the disease.

"Without proper care and treatment, an individual becomes more and more likely to have their life severely impacted by the effects of arthritis," said Lakelyn Hogan, caregiver advocate at Home Instead. "We are offering these tips to help family caregivers better understand the needs of their loved one with this disease. Arthritis is the No. 1 chronic condition that brings us into a senior's home and we wanted to share our advice, curated from twenty years of caring for seniors with arthritis."

Keep the following seven tips in mind when assisting loved ones living with arthritis:

Home Instead CAREGivers deliver responsive and customized in-home care to each client's specific needs. Home Instead offers everything from arthritis help to advanced Alzheimer's careto keep them safe at home.

A Caregiver's Guide to Arthritis provides additional tips on how to help a loved one with arthritis. Download the guide at http://www.caregiverstress.com/wp-content/uploads/2014/06/A-Caregivers-Guide-to-Arthritis_web.pdf. For more information on Arthritis Awareness Month events and resources, visit http://blog.arthritis.org/news/arthritis-awareness-month/.

# # #

ABOUT HOME INSTEAD SENIOR CARE Founded in 1994 in Omaha, Nebraska, by Lori and Paul Hogan, the Home Instead Senior Care network provides personalized care, support and education to help enhance the lives of aging adults and their families. Today this network is the world's leading provider of in-home care services for seniors, with more than 1,000 independently owned and operated franchises that are estimated to annually provide more than 50 million hours of care throughout the United States and 12 other countries. Local Home Instead Senior Care offices employ approximately 65,000 CAREGiversSM worldwide who provide basic support services that enable seniors to live safely and comfortably in their own homes for as long as possible. The Home Instead Senior Care network strives to partner with each client and his or her family members to help meet that individual's needs. Services span the care continuum from providing companionship and personal care to specialized Alzheimer's care and hospice support. Also available are family caregiver education and support resources. At Home Instead Senior Care, it's relationship before task, while striving to provide superior quality service.

For the original version on PRWeb visit: http://www.prweb.com/releases/2017/05/prweb14304019.htm

More:
National Arthritis Awareness Month: Family Caregivers Key to ... - Benzinga

Read More...

Why eating fresh fruit could actually lower your risk of diabetes – Well+Good

May 4th, 2017 2:51 pm

Good Food

by Alison Feller, May 4, 2017

You might have heard about papayas probiotic powers, or the mega-nutritous (and protein-packed) jackfruitbut usually when nutrition pros talk about fruit, theyre advising you choose from the low-sugar options(and definitely skip the dried varietyaltogether).

But according to anew study,natures candy may reduce the risk for developing diabetes.

The observational study, published in PLOS Medicine, tracked the health and diet of more than 500,000 adults inChina for seven years. It found that those without diabetes at the start who ate fresh fruit daily were found to have a 12 percent lower risk of developing the disease than those who ate none.

The sugar in fruit is not the same as the sugar in manufactured foods and may be metabolized differently.

And the more frequently they ate it, the lower their diabetes risk: More than three days a week resulted ina 17 percent lower risk of dying from any cause, and a 13 percent to 28 percent lower risk of developing diabetes-related complications (compared to those who consumed fruit less than once a week).

While it sounds greateat more fruit, dont get diabetes!it may also soundcontradictory. If high sugar consumption is a leading cause in developing diabetes and fruits are packed with sugars, is it really smart to OD on oranges?

The sugar in fruit is not the same as the sugar in manufactured foods and may be metabolized differently, the lead author, Huaidong Du, MD, a research fellow at the University of Oxford, tells TheNew York Times.And there are other nutrients in fruit that may benefit in other ways.

So go ahead and pass that pomegranate, pineapple, or pitayajust keep doing it in moderation.

Heres how to make the most of your summer fruits: our ultimate smoothie guide. And FYI you can alsomake yourblended concoction a thing of beauty (AKA Instagram-ready).

See the original post here:
Why eating fresh fruit could actually lower your risk of diabetes - Well+Good

Read More...

Fruit May Have Benefits for Diabetes – New York Times

May 4th, 2017 2:51 pm

New York Times
Fruit May Have Benefits for Diabetes
New York Times
A large study has found that eating fresh fruit may reduce the risk for developing diabetes, and the risk for its complications. Fresh fruit has well-known health benefits. But some experts, and some people with diabetes, question whether its high ...

Continued here:
Fruit May Have Benefits for Diabetes - New York Times

Read More...

Engineering a Solution for Diabetes – Daily Nexus

May 4th, 2017 2:51 pm

An award that could potentially help find a solution to diabetes has been given to an associate professor in the mechanical engineering department at UCSB. Sumita Pennathur received the Visionary Award from the American Diabetes Association, which includes $1.625 million over the course of five years to fund her research.

Pennathur is one of two researchers nationwide who received this award in 2017. The Visionary Award is given to established, experienced investigators with demonstrated success in a different field who want to bring their expertise to diabetes research for the first time.

Im totally out of the field of diabetes. I had nothing to do with it until my daughter was diagnosed, Pennathur said.

Pennathurs daughter was diagnosed with Type 1 diabetes in 2015 when she was four years old.

Type 1 diabetes is an autoimmune disease in which the pancreas produces little to no insulin, a hormone that helps regulate blood sugar. This happens when the bodys immune system attacks and destroys the insulin-producing cells known as beta cells. Without insulin, the body cannot allow sugar to enter the bodys cells to produce energy.

Currently, the causes of Type 1 diabetes are not known, and the most effective way of treating it is through insulin therapy. Although effective, the treatment includes constant blood glucose monitoring that involves pricking finger tips and finding a way to get insulin into the body.

The Pathways to Stop Diabetes Initiative is aimed at addressing the shortage of research talent in diabetes. The ADA believes that by supporting researchers like Pennathur, they can help generate new solutions to these critical problems. Kevin Son/Daily Nexus

My daughter has to take 10 [insulin] shots a day in her stomach, maybe five but sometimes 10, Pennathur said. She needs to do the shots by herself in her stomach. Shes six years old. Imagine being a little kid and having to do that all the time.

Her daughters diagnosis has inspired her to address the challenge of diabetes monitoring, or continuous glucose monitoring (CGM).

More than several hundred attempts have been made to develop a technique for CGM, but only a couple of them have received FDA approval. The CGM devices currently on the market, including subcutaneous needles that stay in the body for about a week, need to be calibrated twice daily and can give inaccurate readings.

Instead of a monitor that remains inside of the body, Pennathur and her research group have planned to develop a daily disposable patch.

We have to make it disposable because you dont want to stick stuff in your body. Its like a Band-Aid. Were making it like a Band-Aid, Pennathur said.

Although a small device, the patch combines engineering, chemistry and biology, which requires help from other departments.

On campus were doing a patch, so its like an array of needles so its not individually going in and out; its all at once. On the patch is a little hydrogel just think of it as a gooey gel and inside that gel is a bunch of chemicals that were working [on] with [Guillermo] Bazan of the chemistry department, Pennathur said. Hes building a chemical that can not only, if glucose is there, recognize it, but when it recognizes it, it changes its structure so that it fluoresces differently. Itll amplify the fluorescence a lot if the glucose is there.

As of now, Pennathur and her group have built the microneedles and have established how to make the necessary chemicals.

We actually just figured it out. The postdoc is named Bing Wang and hes in Bazans group. He has just figured out the path hes going to take to [make] the gel. Its a bunch of steps. You have to build the chemistry, make sure it works, proof of concept and so he figured out the steps and now we get to do all the steps. Were hoping itll get done in a year, Pennathur said.

Karen Scida, a postdoc who is a part of Pennathurs group is testing the patch and making sure it accurately measures glucose at different levels. Additionally, Scida is coming up with a way of incorporating a thin layer of insulin on the patch itself.

It could talk to the glucose monitor, so its just an artificial pancreas. In other words, you dont have to keep measuring. No finger pricks, its just a patch and you can eat whatever you want to eat, Pennathur said.

Pennathurs approach seems to be the most promising one, but interestingly enough, her background is not in chemistry or biology. She received her bachelors and masters degree in aerospace engineering at the Massachusetts Institute of Technology (MIT) and her Ph.D. in aerospace engineering at Stanford.

I feel really lucky because I got some of the best education you could possibly get in building these things, and now Im a professor on these things and I want to build a medical device, so the fact Im doing this is terrible serendipity, Pennathur said. I dont want to say serendipity because that has a good connotation. This is terrible what happened to my daughter but at the same time Im going to fix it. No one is going to stop me. My motivation knows absolutely no bounds because this is the most important thing in my life my daughter and Im going to save her life.

With a problem this big, Pennathur believes that a solution can be found in areas outside the typical research.

Its interesting because a lot of times, for these types of problems, you need to think outside the box. You need innovative solutions. You got to do stuff that nobody else knows about, and somebody coming from aerospace engineering, right? Who would know that that person could do research in diabetes, and thats because theres all these things I know, like I build microneedles. I know how to build microneedles, I can make them better than anyone. I can physically go in the clean room and make them myself. People who study diabetes cant make microneedles, Pennathur said.

It is the skills she developed as an engineer that could find help find a way to continuously monitor blood glucose levels.

Its those extra little things you learn that help you get somewhere in life. Again, I hate using the word serendipity, but Ive been trying to do this all my life. I didnt really have some problem to solve; I was just making my tools, and then my daughter got diagnosed and now I have my problem to solve, Pennathur said. Theres nothing else Im going to do but this, and I am so blessed to have the tools in my toolbox to actually try to help. Im going every way and any way to make this happen as quickly and efficiently as humanly possible.

Read this article:
Engineering a Solution for Diabetes - Daily Nexus

Read More...

Diabetes’ prevalence can be managed with diet, exercise | Lifestyles … – Journal Gazette and Times-Courier

May 4th, 2017 2:51 pm

May the fourth be with you ... Sorry, I just couldnt help myself. Happy (early) Cinco de Mayo and Kentucky Derby Day, too! I hope youve gotten your tickets and will be joining us at your LifeSpan Center this Friday or Saturday to celebrate with us. I guarantee we will offer you delicious food and beverages, some laughs, and a great time.

Before we have that good time, lets get serious for a few minutes. Nearly 29.1 million Americans and one fourth of adults over the age of 65 have diabetes, a serious disease in which blood sugar (glucose) levels are above normal. Most people with diabetes have type 2, which used to be called adult-onset diabetes. At one time, type 2 diabetes was more common in people over age 45, but now, even children have the disease.

Diabetes can lead to problems such as heart disease, stroke, vision loss, kidney disease, and nerve damage. One out of four people do not know they have diabetes. Many people dont find out they have diabetes until they are faced with problems such as blurry vision or heart trouble. That's why you need to know if you are at risk for diabetes. This is nothing to brush to the side and ignore, folks.

The importance of managing diabetes to prevent diabetes-related health problems such as heart attack, stroke, kidney disease, vision loss, and amputation is very real. More and more people are being diagnosed with it every day. Approximately one-half of older adults have prediabetes. Scary!

And to add to the drama, many older adults may not show classic symptoms of hyperglycemia (including, but not limited to confusion, dizziness, hunger, and sweating). The extra glucose in the blood accumulates in the kidneys until the kidneys see it as an impurity to be filtered out. Common symptoms are dehydration, dry eyes, dry mouth, confusion, incontinence, and diabetes complications, such as neuropathy or nephropathy.2.

Regardless of age, diabetes is often a life-long condition and requires careful treatment. Eating better, sticking to a healthy diet that is low in sugar (including sugar from fruit) and saturated fats is the first step. It may help to see a registered dietitian nutritionist (RDN) who is a diabetes educator to help you create a healthy meal plan. Medicare will cover the visits every year so you wouldnt have to pay out of pocket for the visit.

Aerobic exercise can help you control your glucose level, manage your weight, and stay strong. The American Diabetes Association recommends exercising 30 minutes each day, at least five days a week. You can split up the exercise into 10-minutes of activity three times a day. In addition, do strength training such as free weights, resistance bands, or yoga, at least two times per week. Strength training builds muscle and helps control glucose levels.

Monitoring your blood sugar levels and taking your prescribed medications correctly is also a must. Your health care team should look at all of your health issues, and help mold a plan that is individualized for you. You should see a certified diabetes educator (CDE) to learn about all the aspects of self-management that you will need to know in order to diminish your risks for the complications of diabetes.

Six month from now millions of Americans will observe National Diabetes Month. So many people suffer from this disease and it is observed every November to bring attention to diabetes and its impact on millions of Americans. It also serves as a reminder to people who may be struggling with the demands of managing diabetes that they are not alone.

Living with diabetes has its ups and downs, but healthy lifestyle choices can give you more control over them. And more control means fewer health problems down the road and a better quality of life now.

The Coles County Council on Aging offices are located at the LifeSpan Center, 11021 E. Co. Rd. 800N, Charleston. The telephone number is 217-639-5150 for the Coles County Council on Aging and LifeSpan Center. Come join us each weekday at noon for Lunch at LifeSpan.

Peace Meals, sponsored by Sarah Bush Lincoln Health Center, are served Monday through Friday at a suggested donation of $3.50. To register, reserve a lunch or learn more, call 217-348-1800.

Read the original post:
Diabetes' prevalence can be managed with diet, exercise | Lifestyles ... - Journal Gazette and Times-Courier

Read More...

CDC reports diabetes is on the rise among children – News 5 Cleveland

May 4th, 2017 2:51 pm

CLEVELAND - An alarming number of new cases of diabetes are being diagnosed among American kids. A CDC report revealed last month that Type 1 and Type 2 diabetes are both on the rise.

The findings have doctors raising concerns and making sure parents know the signs and symptoms of diabetes among their children.

She just wasnt acting right but it was nothing I had experienced with the other children, said Tiffany Barzacchini.

Barzacchinis 7-year-old daughter was just 1 year old when she was rushed to the ER with the tell-tale symptoms of diabetes.

She was just lethargic at times, craving water, and by the third day of this, her breathing became real intense, said Barzacchini.

Isola is the youngest of five. None of her older siblings have ever displayed symptoms of diabetes and genetically, theres no trace of the disease in either her moms or dads family history.

The CDC is reporting though that Isola is not alone. In a ten year study of kids from just a few months, to 19-years-old it was discovered each year, there was an increase of 1.8% of new Type 1 diabetes cases and an increase of 4.8% of new Type 2 cases.

Frankly, we dont know the cause, said Dr. Roy Kim, the Section Head of Pediatric Endocrinology at the Cleveland Clinic Children's Hospital.

Kim finds the surge in new diabetes cases alarming.

We know that individuals must have a certain genetic predisposition to be at risk for Type 1 Diabetes but there must be other environmental triggers and frankly we just havent figured out what those triggers are, he said.

An increase in Type 2 among kids can be linked to an increase in overall American childhood obesity. Type 2 is directly tied to weight gain, lack of exercise, and unhealthy eating habits. But whats more confusing is a rise in Type 1, a lifelong condition, with the root cause still unknown.

What goes underappreciated is how life changing the diagnosis is for those kids and what they have to go through, said Kim.

It doesnt ever go away, you dont ever get a break from it, it is literally 24/7 that you have to manage it, said Barzacchini.

For Isolas family, managing her disease is a full time job. Her blood is checked for insulin first thing in the morning when she wakes up, at every meal and after physical activity which must be limited.

Its the same story for millions of Americans. According to the American Diabetes Association, every 23 seconds in this country, theres a new diabetes diagnosis. Its estimated those patients will pay around $14,000 a year in medical expenses dealing with the disease.

Ultimately in her lifetime Im hoping they have a cure, said Barzacchini.

Symptoms parents should be on the lookout for include increased thirst and urination among their children, a feeling of constant exhaustion or hunger, sometimes weight loss and in its severe form, Type 1 can lead to vomiting, severe dehydration, and a coma-like state.

See more here:
CDC reports diabetes is on the rise among children - News 5 Cleveland

Read More...

Poxel shares jump 40% after diabetes trial hits primary goal – FierceBiotech

May 4th, 2017 2:51 pm

A phase 2b trial of Poxels Type 2 diabetes candidate imeglimin has met its primary endpoint. The data sent shares in Poxel soaring 40% and set the company up to push into a phase 3 trial before the end of the year.

Investigators in Japan enrolled 299 patients and randomized them to receive one of three doses of imeglimin or placebo. Participants received the treatment twice a day for 24 weeks. The primary endpoint looked at glycated hemoglobin A1c, a type of hemoglobin that shows the three-month average plasma glucose concentration. A secondary efficacy endpoint looked at levels of fasting plasma glucose.

All three doses of imeglimin outperformed placebo in terms of reducing levels of the hemoglobin. The response was dose dependent. Subjects who received the lowest, 500 mg dose experienced a reduction of 0.52%. Participants who took the highest, 1500 mg dose experienced a reduction of 1.00%. The declines are larger than those seen in earlier trials in the U.S. and Europe.

Dose dependency was also evident in the analysis of the secondary endpoint. Only the two higher doses1000 mg and 1500 mgmet that endpoint. Analysis of additional secondary endpoints is ongoing. Poxel said the safety profile was consistent with that seen in earlier trials. Those studies found the safety profile of imeglimin was comparable to placebo.

Buoyed by the data, Poxel plans to talk to regulators in Japan in the third quarter and kick off a phase 3 study in the fourth quarter. That would set Poxel up to generate pivotal data in a market that is central to its plans.

In Japan, we believe imeglimin may be a prime candidate for first-line treatment as monotherapy and as an add-on to other glucose lowering therapies for the treatment of patients with Type 2 diabetes, Poxel CEO Thomas Kuhn said in a statement. Japan represents the second largest single market for Type 2 diabetes and is expected to grow to approximately $6 billion (5.5 billion) in annual sales in 2020.

Kuhn has previously expressed a willingness for Poxel to run clinical trials of imeglimin in Japan without the support of a partner but bring someone on board to handle commercialization. Poxel raised 26.5 million last year to fund a phase 3 trial in Japan. That round came two months after Poxel floated the idea of a Nasdaq IPO, only to back away in the face of an unreceptive market.

The development strategy in Europe and the U.S. is different. Poxel has long expressed an interest in partnering the asset in those markets before taking it into phase 3.

Merck Serono spinout Poxel thinks imeglimin can claim a slice of the diabetes market by affecting the bioenergetics of mitochondria and, in doing so, preserve the function of beta cells.

View original post here:
Poxel shares jump 40% after diabetes trial hits primary goal - FierceBiotech

Read More...

Diabetes prevention and treatment cooking classes start May 18 – Estes Park Trail-Gazette

May 4th, 2017 2:51 pm

Local instructor Chazz Glaze will cover important diabetes-nutrition topics during this course. (Courtesy photo)

The Physicians Committee for Responsible Medicine (PCRM), a nonprofit dedicated to promoting preventive medicine, is offering a cooking class designed to help local residents with type 2 diabetes avoid complications from the disease and reduce or eliminate the need for medications.

Food for Life: The Power of Food for Diabetes Nutrition and Cooking Class will be held Thursdays from May 18 to June 8 at Salud Family Health Center, 1950 Redtail Hawk Dr. There is a suggested donation of $10 to attend the classes.

The course teaches participants how food choices can prevent and treat type 2 diabetes and arms them with practical cooking skills for making healthy and delicious meals. People who have type 2 diabetes, or concerns about developing diabetes and their friends and family members will benefit from the class.

"Research shows type 2 diabetes can be controlled and even reversed with a healthy plant-based diet," said Susan Levin, M.S., R.D., the director of nutrition education for PCRM. "A vegan diet can help people with diabetes control blood sugar more effectively than the standard diabetes dietary regimen."

The class, designed by physicians, diabetes educators, registered dietitians and professional chefs, offers an easy-to-follow dietary approach based on scientific research. Population studies and clinical research show that a low-fat, plant-based diet is effective at improving blood glucose levels, promoting weight loss, reducing cholesterol and lowering the risk of diabetes and other chronic diseases.

Local instructor Chazz Glaze will cover important diabetes-nutrition topics and guide students through the preparation of tasty and easy-to-prepare recipes. Participants will watch a 30-minute DVD featuring Neal Barnard, M.D., speaking on the role of meal planning, as well as inspiring interviews with people who reversed their diabetes with a vegan diet. They will also enjoy food samples of the recipes prepared in class.

The class details are as follows:

Thursday, May 18, 5:30 to 7:30 p.m. How Foods Fight Diabetes

Thursday, May 25, 5:30 to 7:30 p.m. The Power of Your Plate (and Grocery Cart)

Thursday, June 1, 5:30 to 7:30 p.m. Understanding Type 2 Diabetes and Recognizing and Treating Low Blood Sugar

Thursday, June 8, 5:30 to 7:30 p.m. Designing a Diet for Maximum Weight Control

Students will leave the class with delicious recipes, information on how to switch to a vegan diet and additional diabetes resources, including information on online webcasts and group support. Participants are strongly encouraged to work with their health care team to safely make dietary changes.

For more information about the Food for Life Diabetes Nutrition and Cooking Class program or to register for the classes, email Glaze at aveganwithaltitude@gmail.com or call (970) 235-1586.

Read the original:
Diabetes prevention and treatment cooking classes start May 18 - Estes Park Trail-Gazette

Read More...

Scientists are waging a war against human aging. But what happens next? – Vox

May 4th, 2017 2:48 pm

We all grow old. We all die.

For Aubrey de Grey, a biogerontologist and chief science officer of the SENS Research Foundation, accepting these truths is, well, not good enough. He decided in his late twenties (hes currently 54) that he wanted to make a difference to humanity and that battling age was the best way to do it. His lifes work is now a struggle against physics and biology, the twin collaborators in bodily decay.

He calls it a war on age.

Grey considers aging an engineering problem. The human body is a machine, he told me in the following interview, and like any machine, it can be maintained for as long as we want.

This is not an isolated view. There is a broader anti-aging movement afoot, which seems to be growing every day. As Tad Friend describes colorfully in a recent New Yorker essay, millions of venture capital dollars are being dumped into longevity research, some of it promising and some of it not. Peter Thiel, the billionaire co-founder of PayPal, is among the lead financiers (hes a patron of Greys organization as well).

Greys work is particularly interesting. For too long, he argues, scientists have been looking for solutions in all the wrong places. There is no monocausal explanation for aging. We age because the many physical systems that make up our body begin to fail at the same time and in mutually detrimental ways.

So hes developed what he calls a divide-and-conquer strategy, isolating the seven known causes of aging and tackling them individually. Whether its cell loss or corrosive mitochondrial mutations, Grey believes each problem is essentially mechanical, and can therefore be solved.

But even if this Promethean quest to extend human life succeeds, several questions persist.

If we develop these anti-aging technologies, who will have access to them? Will inequality deepen even further in a post-aging world? And what about the additional resources required to support humans living 200 or 300 or 500 years? The planet is stretched as it is with 7 billion people living roughly 70 years on average (women tend to live three to five years longer than men) and is already facing serious stresses around food, water, and global warming going forward.

Grey, to his credit, has thought through these problems. Im not sure hes alive to the political implications of this technology, specifically the levels of state coercion it might demand.

But when pressed, he defends his project forcefully.

Is there a simple way to describe theoretically what the anti-aging therapies youre working on will look like what theyll do to or for the body?

Oh, much more than theoretically. The only reason why this whole approach has legs is because 15 or 17 or so years ago, I was actually able to go out and enumerate and classify the types of damage. We've been studying it for a long time, so when I started out in this field in the mid-90s so I could learn about things, I was gratified to see that actually aging was pretty well understood.

Scientists love to say that aging is not well understood because the purpose of scientists is to find things, out so they have to constantly tell people that nothing is understood, but it's actually bullshit. The fact is, aging is pretty well understood, and the best of it is that not only can we enumerate the various types of damage the body does to itself throughout our lives, we can also categorize them, classify them into a variable number of categories

So I just talked about seven categories of damage, and my claim that underpins everything that we do is that this classification is exhaustive. We know how people age; we understand the mechanics of it. There is no eighth category that were overlooking. More importantly, for each category there is a generic approach to fixing it, to actually performing the maintenance approach that I'm describing, repairing the damage.

Can you give me an example of one of these categories and what the approach to fixing it looks like?

One example is cell loss. Cell loss simply means cells dying and not being automatically replaced by the division of other cells, so that happens progressively in a few tissues in the body and it definitely drives certain aspects of aging. Let's take Parkinson's disease. That's driven by the progressive loss of a particular type of neuron, the dopaminergic neuron, in a particular part of the brain.

And what's the generic fix for cell loss? Obviously it's stem cell therapy. That's what we do. We preprogram cells in the laboratory into a state where you can inject them into the body and they will divide and differentiate to replace themselves that the body is not replacing on its own. And stem cell therapy for Parkinson's disease is looking very promising right now.

Is it best to think of aging as a kind of engineering problem that can be reversed or stalled?

Absolutely. It's a part of technology. The whole of medicine is a branch of technology. It's a way of manipulating what would otherwise happen, so this is just one part of medicine.

But you're not trying to solve the problem of death or even aging, really. Its more about undoing the damage associated with aging.

Certainly the goal is to undo the damage that accumulates during life, and whether you call that solving aging is up to you.

What would you say is your most promising line of research right now?

The great news is that we have this divide-and-conquer strategy that allows us to split the problem into seven subproblems and address each of them individually. That means we're constantly making progress on all of them. We pursue them all in parallel. We actually don't pursue stem cell therapy very much, simply because so many other people are doing it and basically everything really important is being done by somebody else, so it's not a good use of our money.

We're a very small organization. We only have $4 million a year to spend, so we're spread very thin. We're certainly making progress. Over the past year we've published really quite high-profile papers relating to a number of main research programs, so there's no really one thing that stands out.

What do you say to those who see this as a quixotic quest for immortality, just the latest example of humanity trying to transcend its condition?

Sympathy, mainly. I understand it takes a certain amount of guts to aim high, to actually try to do things that nobody can do, that nobody's done before. Especially things that people have been trying to do for a long time. I understand most people don't have that kind of courage, and I don't hate them for that. I pity them.

Of course, the problem is that they do get in my way, because I need to bring money in the door and actually get all this done. Luckily, there are some people out there who do have courage and money, and so we're making progress.

Ultimately, the fact is aging has been the number one problem of humanity since the dawn of time, and it is something that, until I came along, we have not had any coherent idea how to address, which means the only option available to us has been to find some way to put it out of our minds and find a way to get on with our miserably short lives and make the best of it, rather than being perpetually preoccupied with this ghastly thing that's going to happen to us in the relatively distant future. That makes perfect sense. I don't object to that.

The problem is that suddenly we are in a different world where we are in striking distance of actually implementing a coherent plan that will really work, and now that defeatism, that fatalism, that resignation, has become a huge part of the problem, because once you've made your peace with some terrible thing you know, it's very hard to reengage.

Are there any ethical questions or reservations that give you pause at all?

Not at all. Once one comes to the realization that this is just medicine, then one can address the entire universe of potential so-called ethical objections in one gut. Are you in favor of medicine or not? In order to have any so-called ethical objection to the work we do, the position that one has to take is the position that medicine for the elderly is only a good thing so long as it doesn't work very well, and thats a position no one wants to take.

Ive no doubt youve been asked this question before, but I think its too important to gloss over. You talk enthusiastically about transitioning to a post-aging world, but there are many people who worry about what it means to increase the humans time on earth. We dont necessarily have an overpopulation problem, but we certainly have an inequality problem, and we seem to need more resources than we have. If 90 percent of people die from aging now, and suddenly people are living for 200 or 300 years, how will we be able to sustain this kind of growth?

First of all, thank you for prefacing the question with the thought that I've probably heard this question a lot, because of course I have. But you'd be astonished at how many people have presented this question to me starting with, "Have you ever thought of the possibility that..." as if they genuinely had a new idea.

But yes, overpopulation is the single biggest concern that people raise, and I have basically three levels of answers to these questions. First, the answer is specific to the individual question. So in the case of overpopulation, essentially I point to the fact that fertility rates are already plummeting in many areas. And people often forget: Overpopulation is not a matter of how many people there are on the planet but rather the difference between the number of people on the planet and the number of people that can be on the planet with an acceptable level of environmental impact, and that second number is of course not a constant; it's something that is determined by other technologies.

So as we move forward with renewable energy and other things like desalinization to reduce the amount of pollution the average person commits, we are increasing the carrying capacity of the planet, and the amount of increase that we can expect over the next, say, 20 years in that regard far exceeds what we could expect in terms of the trajectory of rise in population resulting from the elimination of death from aging. So that's my main answer.

The second level of answer is at the level of sense of proportion. Technology happens or doesn't happen, whatever the case may be, and maybe the worst-case scenario is that we will end up with a worse overpopulation problem than what we have today.

What does that actually mean? It means we're faced with a choice in a post-aging world, in a world where the technology exists a choice between either, on the one hand, using these technologies and having more people and having fewer kids than we would like or, on the other hand, letting stuff go on the way it is today, which involves not using technology that will keep people healthy in old age and therefore alive.

Ask yourself, which of those two things would you choose? Would you choose to have your mother get Alzheimer's disease or to have fewer kids? It's a pretty easy choice, and people just don't do this.

The third level is perhaps the strongest of all, which is that it's about who has the right to choose. Essentially if we say, Oh, dear, overpopulation, let's not go there. Let's not develop these technologies, then what we are doing as of today is we are delaying the arrival of our technology. Of course it will happen eventually. The question is how soon? That depends on how hard we try.

If we know that, then what we're doing is we're delaying the arrival of the technology and thus condemning a whole cohort of people of humanity of the future to the same kind of death and disease and misery that we have today in old age, when in fact we might have relieved that suffering had we developed the therapies in time.

I dont want to be responsible for condemning a vast number of people to death. I dont want to be in that position. I think theres a strong argument that we should get on developing these technologies has quickly as we can.

I take your points there, but those questions are far easier to answer in theory than they are to solve in practice. For instance, we cant simply decide that people will have fewer children without potentially dangerous levels of state coercion. The politics of this is complicated at best, dystopian at worst.

In any event, let me at least raise one more concern. What is your sense of the cost and the accessibility of these therapies should they become available? People concerned with bioengineering, for example, worry that technologies like this, if they arent equally distributed, will produce inequalities of the sort weve never seen before and cant sustain.

Its a valid concern. It needs to be addressed, but luckily, like the overpopulation one, it's a really easy one to address. Today what we see with high-tech medicine is that it is even in countries with a single-payer system it's pretty much limited by the pay because there's only so much resources available.

But part of the problem now is that our current therapies for elderly people dont work well. It postpones the ill health of old age by a very small amount if we're lucky, and then people get sick anyway, and we spend all the money that we would have spent in absence of the medicine just keeping the person alive for a little longer in a miserable state.

Now compare that with the situation where the medicine actually does work, where the person actually stays healthy. Yes, they live a lot longer, and sure enough, it may be that we have to supply these therapies multiple times because they are inherently periodic therapies, so we could be talking about a substantial amount of money. But the thing is these people would be healthy, so we would not be spending the money on the medicine for the sick people that we have today.

Plus, on top of that, there would be massive indirect savings. The kids of the elderly would be more productive because they wouldn't have to spend time looking after their sick parents. The elderly themselves would still be in an able-bodied state and able to actually contribute wealth to society rather than just consuming wealth.

Of course, there are lots and lots of big uncertainties in these kinds of calculations, but there is absolutely no way to do such a calculation that does not come to the absolutely clear conclusion that the medicines would pay for themselves many times over, really quickly.

So what that means, from the point of view of government setting aside the fact that it would be politically impossible not to support this is that it would be suicidal from a purely mercenary economic point of view not to do this. The country will go bankrupt because other countries will be making sure their workforce is able-bodied. The world will be frontloading their investments to ensure that everybody who is old enough to need them will get these therapies.

When will the therapies youre developing be ready for human experimentation?

That will happen incrementally over the next 20 years. Each component of the SENS panel will have standalone value in addressing one or another disease of old age, and some of them are already in clinical trials. Some of them are a lot harder, and the full benefit will only be seen when we can combine them all, which is a long way out.

How confident are you that someone alive today will not die of aging?

It's looking very good. Of course this is primary technology, so we can only speculate. It's very speculative what the time frame is going to be, but I think we have a 50-50 chance of getting to work on longevity escape velocity, the point where we are postponing the problem of aging faster than time is passing and people are staying one step ahead of the problem. I think we have a 50-50 chance of reaching that point within 20 years of now, subject only to improved funding on the early-stage research that's happening at the moment.

Escape velocity is an interesting analogy. The idea is to keep filling up the biological gas tank before it runs out, staying a step ahead of the aging process?

Right. The point is that these are rejuvenation therapies, which means they are therapies that genuinely turn back the clock. They put the body into a state that is analogous or similar to how it was at an earlier [stage] rather than just stopping or slowing down the clock. Every time you do this, you buy time, but the problem gets harder because the types of damage that the therapy reverses will catch up, and those imperfections just need to be progressively partially eliminated. The idea, then, is that you asymptotically approach the 100 percent repair situation but you never need to get there. You just need to keep the overall level of damage below a certain tolerable threshold.

For more about de Grey's work, visit the SENS website.

Continue reading here:
Scientists are waging a war against human aging. But what happens next? - Vox

Read More...

Field of vision: Despite blindness in left eye, West Forsyth’s Berry is … – Winston-Salem Journal

May 4th, 2017 2:48 pm

Brooklyn Berry has seen and done many things in her three seasons on the West Forsyth girls soccer team.

Berry, however, is limited in what she can see. The Titans talented junior forward has been blind in her left eye since eighth grade.

I tore half my retina, but the half that I tore is the half that we dont use. So I never knew it, Berry said. One day I couldnt see anything. I started losing vision, so I went to the doctor, and they told me that I had torn the half that I didnt use. And they told me it had been torn for months or years.

They told me that couldnt tell how long or what caused it because it had been so long.

Despite playing a majority of the time on the right side of the field, the lack of vision has not slowed her down.

She broke one of Alison Prices records on Tuesday and is on pace to break another. Berry broke the single-season school record of 43 goals, which was held by Price, a rising senior at Louisville, on Tuesday at Reynolds. She scored three times and now has 44 for the season.

Berry, who has verbally committed to UNC Wilmington, now has 104 career goals, 10 short of tying Prices all-time record of 114 at West Forsyth.

The cause of the injury to Berrys eye was never figured out.

Ive had so many concussions, so they told me it could really be anything, Berry said. And they told me it was just a matter of time until the rest of it (retina) fell off. So I had to get retina surgery.

The doctors inserted a new lens, but it didnt take.

I had surgery, and I had to wear an eye patch. I could only sleep on my left side. There were a bunch of things I was supposed to do. The lens shifted after, like, two days, and I went blind again, Berry said.

Some people, the lens just doesnt take. Your body just rejects it. My body just didnt take it right.

Coach Scott Bilton knew of Berrys blindness before she came to West Forsyth.

Its just been such a driving force for her, Bilton said. Shes compensated for that with the way that shell position her body so that shes able to see everything she needs to and things of that nature.

Adjusting to being able to see in just one eye has been difficult.

The first season, I had to play on the left side. Its been three or four years, so its still kind of hard, Berry said. I sometimes run into people and I dont really notice it. Ill be running and therell be somebody on my left side, and I cant really tell.

A lot of people on my team, they forget. Ive definitely gotten used to it a lot better than I used to.

Berry is not immune to injuries breaking her elbow her freshman year, pulling both hamstrings last season, and she is currently playing with a stress fracture in her foot.

In his 10th season coaching the Titans, Bilton has never seen anything like this.

Its definitely different, I guess, Bilton said. And its, obviously, something thats shocking to do what shes able to do. Shes had broken bones, just a bunch of stuff. Shes just found a way to be successful.

The Titans just clinched their seventh straight Central Piedmont 4-A conference championship and have won eight of the last 10. Before the Reynolds game, they were 18-1-1 and 10-0 with just a 4-1 loss to Cornelius Hough on April 21.

Berry has been there for the past three championships, scoring 27 goals her freshman season and 33 last season.

If the Titans make a deep run in the NCHSAA Class 4-A tournament, which starts next week, she could threaten Prices school scoring record this season. The team reached the state semifinals last season, losing 1-0 to Charlotte Providence.

The all-time state record, according to the NCHSAA, is 217 set bet Carolyn Lindsay of Hope Mills South View from 2000-03. It is possible for Berry to reach the top 15 on the list next season. Elizabeth Spencer, who played at Wilson Fike from 1996-99, has 152 goals.

The Forsyth County record set by Leigh Murray, who played at East Forsyth 1986-89, is 169 goals.

Berry said she hasnt spoken to Price about the record.

Shes a competitor, first and foremost, Bilton said of Berry. And competitors, when they set a goal, thats something that they want to go for.

Continued here:
Field of vision: Despite blindness in left eye, West Forsyth's Berry is ... - Winston-Salem Journal

Read More...

Mexico eliminates infectious disease which is leading cause of … – The Yucatan Times

May 4th, 2017 2:48 pm

In a significant public health victory, Mexico has succeeded in eliminating a disease which is the leading cause of blindness worldwide, reportsNBC News.

The Pan American Health Organization (PAHO) and the World Health Organization (WHO) announced last weekthat Mexico is the first country in the Americas to eliminate trachoma as a public health issue. The disease, caused by a microorganism, affects the eye and repeated infections can lead to scarring and even loss of vision.

It primarily affects young children, and can be spread by personal contact or by flies that have been in contact with the discharge from the eyes or nose of an infected person.

This is a historic moment for public health in Mexico and the Americas, said Carissa F. Etienne, Director of the Pan American Health Organization (PAHO), WHO regional office for the Americas. Eliminating a disease is not achieved every day.

(Photo: Google)

Trachoma primarily affects poor and isolated populations in 41 countries; in the Americas, the disease is still prevalent in Brazil, Guatemala, and Colombia.

Mexico has become the third country, after Oman and Morocco, to receive WHO validation for eliminating the disease.

In Mexico, trachoma affected over 146,000 people. The country ramped up its actions in 2004 with the creation of the Trachoma Prevention and Control Program of the Ministry of Health of Chiapas and the strengthening of the WHO SAFE strategy. The Trachoma Brigades focused on cleanliness, antibiotics, environmental improvement and surgery for the advanced stage of the disease.

The programs slogan was With water, soap and cleanliness you can prevent trachoma. Teachers at schools would also meet with parents regularly to promote better hygiene.

The international criteria for the elimination of trachoma as a public health problem includes prevalence of less than 5 percent in children aged 1 to 9, and less than one case of trachomatous trichiasis (inverted eyelashes) per 1,000 inhabitants.

Source: http://www.nbcnews.com/news/latino/

comments

Visit link:
Mexico eliminates infectious disease which is leading cause of ... - The Yucatan Times

Read More...

Cell-free biotech will make for better products – The Economist

May 4th, 2017 2:47 pm

isW%}~dL6_bZge&Y,@@`"@P$[}=>_"+YdTx?]r]Ze__Grj}}}^m_"}^mgoZ]~ 7_mw_^mgWOO;]t^e<=w5>b)"Wm/WQ}uW__J_gz>nkm/'qS7Jnw~uTsqU1_.jw8_;[(g+rz{K,.l|+b__^4urU6|}~Ye"u^m! Ung^e6tZe'"h.?.;Y]_vn|]z=N|/rq'>N :|{~wzmO*~ugw2;/?d'}-6x]]l[e-nVM|zvUlbz>fw^V.`nlq^~_,W{y~#?ooS|/7}D];w7-M]Wq7~x-a)yluyv~Z/znW8(/7>;ENq"_|z.t<=m_,,.>&//^)]#mmG)r:8xpW*;,KkjkBU:'XU>,NS~ T[<*mw6'nG;i'Q9'i,ydgd?PL$ys_v:+Ers~o6oK_eQF9_GS|y~~/7(+cw{7WYSqSE~3G1rtq#MGj"_EFcl}qmV)K_UcJg}jW.Nap89.?D,C6>U~uslQ>}U?NclO|__+Q^V;&z;v[7gynV+k#>-O]E]Ylrkvt'HeU4j=mkzqVM[u'.)M46B}Z&T]h_6qbVKM9nb76t)+_.Nb]-lk[_/57xiOd1~P9sjNMp''[dysSu~wO esrU-MS -vhW|UfmCP./VN5,7qmKLEhlK]Y{/4>5_h[hyXuUvTu(&:iOx|:s"y4 raLaqE;Y6(@g)4 jyZ,}5=We=.|[W`]WZTv=Y'<9]Y_97WuVQ2_G|"*ju _./)]l'Ocz%WgvpRD~93?yw}snj]>l__-KyZz0#s[]W:l^LX>5~~,/"}YkQyGwov=gqnT_mYxKvxkO8W]*t&wfLvB~z-#I;GVrurS.^>KwTik#o8` cN$?(VL248o7W3 O.Nc+37OMQNd&{&~w:|fA6)Z+|M9oFM^ns1d)={^_o?ZG>ms=X~/.64}3z6)+n_LS.Wg_gu:k!e ,!1S7xZ1U6Qe5r;-,~SWvOUoz`t/)hwnun[Q{@gXR]M9Vr2SxCv1In%zN#}=<]~zwBp}?niN}OX%9FmVS>#z[#nh7dyC%rw8$5ARz,!e'$}3}"i'$- *ssN&snWo&#O}N;xCNNHoQNN&ONXFu-sG ZlgQJ>nQcX9l5A`=R]Vv7r.8|5W!dln"tQkte|M jz>L\T=2de}3%X!R{W;2Q5=:kT7|Nebf33.'q]$xNj4:scNBnL==K<.afdoHC,|h{n#v]u'e3K< X}$IOX9c[`d9/":d9&(u 8&{z#zx0/O-4(36tCjs]]pYh/IZ!o(Z{l{92?OlrTB1|VwA{}OG?.=VzO? AU>mzjqouwz[u0F(!D}:t>O(;.0D#O dw(2I[Q&]JwuWz2=7B)xk1'VpyA :

<[`859tyRsj]ut4MISik"MOUsCsQ9'?;S14|dA z~6v'SSQ}W_3?3r>Od4+?wGKpmo2' XcX+,1{ VKA00s;0BwrS<#gp`':4Sg*E~;kV. ~u6u5<;>4,)Fh>e7~LS#c5Q33.)ll0QC&+ym~N8E?-r~[*8eDMRLR6]CcJw{]~#,n6't|]3xRqsLJysY2dYM&}^ME>^&de^g~=_q;S|N?d>Gq;T)o-!9#(g~mXBf (>k^L[[} (}({+dy }xB(l}pBsg%qM~X">_2an.UQUR&KQO;pKw;V5Q^oQ`Y1"3t.?K"=PxTc5RT|*oVrfCEqJ / WupTQnJ7^]^?b,h/ hoIO}S[L+IjdvK>M?&`:!wZXohl{'qB&qLyBS j>e/Z__CxZQ7u2QEY>?~__/rt8v(V5zWOWGXoRSlFq?vw.]C2[oxN4G//vkn}~|fyE_H+ji*j{o!/GsW5*|I"C3AyuaHsA+Mt J4qerEiGo%D qA&.EA;!m~:>17Col[ynFR7R)X9@Fb}M|y|_7OF.QxN;+G'TrBC")bP5p$ GD*ID+ w`)rv-B'@hqK4 #:0Y8bhgdU|jnE/ ky{7lyQ=hH c [j15H6*h0pL"{;Lm,,i%9 .NadQh2_(az3FD..(t 8qdxdZtY!lvmuAkve Lu# ,~-q .SfS&B+Qo,o]aBF)-`} l(1ynBXy7u5j/ 1L(rEpdWAo!#`RT(?cd"v-"bE Um tlVx^ J|#&g@!ZCjR"eDp^]lp~X%b) ,|d]pc:Drzb=>lxk2[8$7cQPBU#sAW5Xe84E'DmDa, *qZbdV)HS&C,nc7@$y}F#Rt$#-)vhl:Nx:SK^<]rPz:!.R1O[:ao@Eh;`|HqShS]$s{`xH^HI2>6.wM@oV=[~t.JHHQR7~R&t#m)wy*D!U)pTO 9.fQW!O:f! jjO":R)lD|N~"oI1GPd'a)^TTA"6HQ:'q8SJHD2850?j!R_q9MR=J7tB;RldIn2qg?4Y C lARti@4 X`$v"oI>o+6E]*nH^J@xYo[j_bU6YX8'BH6 5VDT|or1W #b+tA7+!;]K=-vAMxFW9o$011I^2N1YGJ#q_TDBQ[IaU*p"KaB`2x oh* )]KgQs-I">J8*JG*korDZ@]LB}o&~f#y# 9mo,bK/r! +c

C.J,JQh/lee(@Y&?-hErR$QI0KYVjEFUso]i7B`0fFSYuy i98$hBqIy-F!;@ab075W v( hhgh gk.+f^)R!^q/:Y:.WR +[$;Y er6>O6m*T:PGqG]"W17y+K8jKg HC?xjFt'CC&;0t`XD ~g^e-DFPU(*<`Gw %H9$0?=Qi9% r<&tn)Dc*{ %0{2@K] $m2),u">k1(JK+{hX;:@Z"}^;PZJ/) &GRN4f' pKQpi wU9 viD(E18Rv4rjmG``6O#r(&^3 'xZ5k'Dz{@?w!.|%V}Qb(d u!^7fX3?__._#fUV!V:@7P&k0Q]42Jxja1qlI:j2 33JVa8JI%ryS0Xs*)vC5-3ehFp@F=GV#tu4*|e M.QU t=8*JUJ``&tK6I a~Gqu,(w5G,4+.l)`EiXhhs {ieBq%!/YTfW`)B~[f"#+Lk.Em417 L3Xg< fr lMFmii5COlA;BJA/^%i0jK6g*i3lYS*9bsDH51APuk ~5QG:dYLHh Edo$COOt>n9Y mqb${dx%#xu@%%w%wqn%omOwozc}kk)]kJ=,ufS>qx(5O$,W|YK;PL&fm 3Hs'{72is5Tp<:iA#KDdM~,!^B"~PTt^2xLP:Q&J^DTBiJm3)91&cO2gH@nO pxfM-[HS@E^ %b&_jb 6Odv7)"2dXAR@dBE#7E" >9DcNCFz]}$ [t-* =BpK=sm*FjT*0#dkFKDTH3K^]`Pfr1~n*q]T*T@Eop}}`r d D^wiH/5h60<3pq(`-h&T)M8#wq^;G G:},+ 2O51LnM|`/+nCJ&h7([6; aWxx%8f? A]Zdp'b% _QML%S wc HF)HlS:1L`NU0fgUEzYoXaSs! 90GwYi?LfEo%#411=^o8- (shJ'k!%b2{ aW"K$=K#+1~O{Je;a~J-yB`YcNIt(m6aaCBDBf T!(#ak~HtG6(WxVs0H'][:;5/)=" IqaMX/KhHDG)"`haF#AzyhOU,irs@H)g~i0 8v ZKX/Q(>Aa <.%G9d#CXDb>OF-I%fDTq4MSh%t@=,fIfAd.q)BXHU3aE=QZi'fT$9U Uy^?{G1?L?|VmQ}Huzi?2g)+d j2I7J{Iw20,)/9hH45e/dLWOCRsut0Q5pOnB(hYUU|JPgs27h4*B)7d6.:Xa" ._!I$Q'tX1 y(cu.^$1E~JbYbZ]p2J:=vH{1f6+8T4MC 04A(sK/maF{RQEIL 9LI?U5=r(y~6Jh v( EQM#)e(4 G{ ar$AYvrl4O[O?}FeUxbch!1z't~o$YL3 Bd}D1MaL^L}8RSSB?4Pmz& ^dK~z!gax9p2CP42gEw-c 2^6iZC/6%@#(iQD,ajw 6cIPS%d77=|j};lJ2b<@t32E'~E-,Q)^A)!<_*pRXUgzBENf0a *:8#5Z0]#NNai!vG,Aje?B}e 6*uj{5|vm[]6o["1B1}_IihX!2*CO+:UDDe=FL'v fkA6&/1{?|P^0 22Zm-ZuVx?ZM#tgY60CKa;)*vYvj[;p_$VJBmb! ;FkK!dxKQ4*Ah^`/9Myl$JS]' PEd`vT'QG@X35bTf0Yub|.^emi~H6 SMd/`%t=.J!P 0@-q%i:af,}{n%g`5XzJWB4WXFxN}n8%GE$[@ !XcT*B+DXH1LQG->ZX5(8kR$qW!d)jvwp;|$-fYYB NRTjjX1UU 2}B c!<" $GA i=6va(d4dh$YMgIHLlyB(AkvN$C_Om=fNDrPUz#[T7c9k]rUb "ORw VD8{&kCA=Z% m$EO}:W"s_&kfIa{SOPc"g_F-V2)A]j-|*Kh&V/A!9x,LTi!)F>8SyBTvw&w{!=j.PxYUA# 6Al&AD?O`6<6!v 2)PbQ8C5 X aC;d ck(|eH6nvxS%ni;FVZEzb> {JnJ&h$5]1J0>jg^t4lI/+vX o`(bnQ:d#> VN&>HisVRj>N}4#g^Gu>Q1u9 Xms&pHo C@Y>LOM*,Ofnb{Lhz=ACv@aWj? @rOQ5 nRhT6"{wDR 9LZ g~T+#( {KF89qzp5,BgndJ]uw DU1H%C0xA29`_faqPDY8m %;cQO8X$}4:ePxz-8fW^RqH2&E pBSa18W;?U`0n,:O:qjtS2Sezj|#9vLGb'R}/_zhdk ['z8QP|mA^$ 3d L2$b,Q2t;Fs0-+Yul,Yd"pc%lL)-24$0P(?Su'F B{GJFG6H#Ic#qi3#!) flPcV&JRzLsg1 6L!W%bAm.18AAjB%3X'j{^FaT+ ?heZ,$SYDmOa_4Mg{leb {#[QE3mNz5}(DQ EXyFBP&pHX#( *Fx lHGpTU$Cp$%s(3B%nn$hkTTI De*+,"WUHRyC6P@`d-}7-y8T')T%w'B2J))y5[ z JHJj3] 9:^K@A`SJMT0&(H(wyp'x(k`>yJ:[0`@I^uI AvUb;dXs#=- cTZJH EuPD|,?n}3aSR#n(l40 `Ub`"jyT3jJ:6g';A`1SU2[1W~ XKa9f0U M:=R_Q7}&n(t+1P$9L"=bK{g5;.QS[KAXFfpa( V)@xfjX)8uS(?FL0#W :

Read the original:
Cell-free biotech will make for better products - The Economist

Read More...

Page 1,015«..1020..1,0141,0151,0161,017..1,0201,030..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick